Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients RM Elshazli, EA Toraih, A Elgaml, M El-Mowafy, M El-Mesery, MN Amin, ... PloS one 15 (8), e0238160, 2020 | 269 | 2020 |
Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: a meta‐regression and decision tree analysis EA Toraih, RM Elshazli, MH Hussein, A Elgaml, M Amin, M El‐Mowafy, ... Journal of medical virology 92 (11), 2473-2488, 2020 | 121 | 2020 |
Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling AM El-Mowafy, MM Al-Gayyar, HA Salem, ME El-Mesery, MM Darweish Phytomedicine 17 (14), 1067-1075, 2010 | 90 | 2010 |
Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides ME El-Mesery, MM Al-Gayyar, HA Salem, MM Darweish, AM El-Mowafy Cell Division 4, 1-17, 2009 | 76 | 2009 |
Evaluation of renal protective effects of the green-tea (EGCG) and red grape resveratrol: role of oxidative stress and inflammatory cytokines AM El-Mowafy, HA Salem, MM Al-Gayyar, ME El-Mesery, MF El-Azab Natural Product Research 25 (8), 850-856, 2011 | 71 | 2011 |
Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors MA Zeidan, AS Mostafa, RM Gomaa, LA Abou-Zeid, M El-Mesery, ... European journal of medicinal chemistry 168, 315-329, 2019 | 57 | 2019 |
Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway NFA El-Magd, M El-Mesery, A El-Karef, MM El-Shishtawy Life Sciences 193, 159-170, 2018 | 50 | 2018 |
Bioactive Brominated Oxindole Alkaloids from the Red Sea Sponge Callyspongia siphonella SS El-Hawary, AM Sayed, R Mohammed, HM Hassan, ME Rateb, E Amin, ... Marine drugs 17 (8), 465, 2019 | 48 | 2019 |
Effects of metformin on apoptosis and α-synuclein in a rat model of pentylenetetrazole-induced epilepsy AM Hussein, M Eldosoky, M El-Shafey, M El-Mesery, AN Ali, KM Abbas, ... Canadian Journal of Physiology and Pharmacology 97 (1), 37-46, 2019 | 46 | 2019 |
The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-α and TRAIL-induced apoptosis. El-Mesery M, S ME, E A. Exp Biol Med, 2016 | 40 | 2016 |
CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants J Trebing, M El-Mesery, V Schäfer, D Weisenberger, D Siegmund, ... Cell death & disease 5 (1), e1035-e1035, 2014 | 40 | 2014 |
Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma AO Bashir, ME El-Mesery, R Anwer, LA Eissa Life sciences 254, 117794, 2020 | 36 | 2020 |
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cells M El-Mesery, J Trebing, V Schäfer, D Weisenberger, D Siegmund, ... Cell Death & Disease 4 (11), e916-e916, 2013 | 35 | 2013 |
Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression SM Eraky, M El-Mesery, A El-Karef, LA Eissa, AM El-Gayar Biomedicine & Pharmacotherapy 101, 49-57, 2018 | 34 | 2018 |
Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model SA Helmy, M El-Mesery, A El-Karef, LA Eissa, AM El Gayar Life sciences 233, 116673, 2019 | 33 | 2019 |
Prominent chemopreventive and chemoenhancing effects for resveratrol: unraveling molecular targets and the role of C-reactive protein AM El-Mowafy, ME El-Mesery, HA Salem, MM Al-Gayyar, MM Darweish Chemotherapy 56 (1), 60-65, 2010 | 32 | 2010 |
Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model SA Helmy, M El-Mesery, A El-Karef, LA Eissa, AM El Gayar Chemico-biological interactions 279, 84-94, 2018 | 30 | 2018 |
MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis. El-Mesery M, S A BJP, 2015 | 29 | 2015 |
Changes of gut-microbiota-liver axis in hepatitis C virus infection M El-Mowafy, A Elgaml, M El-Mesery, S Sultan, TAE Ahmed, AI Gomaa, ... Biology 10 (1), 55, 2021 | 28 | 2021 |
Alterations of the treatment-naive gut microbiome in newly diagnosed hepatitis C virus infection S Sultan, M El-Mowafy, A Elgaml, M El-Mesery, A El Shabrawi, M Elegezy, ... ACS Infectious Diseases 7 (5), 1059-1068, 2020 | 27 | 2020 |